- -

Transdermal therapeutic systems for memantine delivery. Comparison of passive and iontophoretic transport

RiuNet: Institutional repository of the Polithecnic University of Valencia

Share/Send to

Cited by

Statistics

Transdermal therapeutic systems for memantine delivery. Comparison of passive and iontophoretic transport

Show full item record

Del Rio-Sancho, S.; Serna-Jiménez, C.; Sebastián-Morelló, M.; Calatayud-Pascual, M.; Balaguer-Fernández, C.; Femenia-Font, A.; Kalia, Y.... (2017). Transdermal therapeutic systems for memantine delivery. Comparison of passive and iontophoretic transport. International Journal of Pharmaceutics. 517(1-2):104-111. https://doi.org/10.1016/j.ijpharm.2016.11.038

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10251/154101

Files in this item

Item Metadata

Title: Transdermal therapeutic systems for memantine delivery. Comparison of passive and iontophoretic transport
Author: Del Rio-Sancho, S. Serna-Jiménez, C.E. Sebastián-Morelló, M. Calatayud-Pascual, M.A. Balaguer-Fernández, C. Femenia-Font, A. Kalia, Y.N. MERINO SANJUÁN, VIRGINIA Lopez-Castellano, A.
Issued date:
Abstract:
[EN] Memantine is a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist used in the treatment of moderate to severe dementia including the symptoms of Alzheimer's disease (AD). It is administered orally but ...[+]
Subjects: Memantine , Transdermal delivery , Occlusive-systems , Chemical penetration enhancers , Iontophoresis
Copyrigths: Cerrado
Source:
International Journal of Pharmaceutics. (issn: 0378-5173 )
DOI: 10.1016/j.ijpharm.2016.11.038
Publisher:
Elsevier
Publisher version: https://doi.org/10.1016/j.ijpharm.2016.11.038
Project ID:
info:eu-repo/grantAgreement/Generalitat Valenciana//AP-114%2F09/ES/Estudio de la administración transdérmica de memantina para el tratamiento de la enfermedad de Alzheimer/
info:eu-repo/grantAgreement/Generalitat Valenciana//AP-155%2F10/ES/Estudio de la administración transdérmica de memantina para el tratamiento de la enfermedad de Alzheimer./
info:eu-repo/grantAgreement/Generalitat Valenciana//AP-175%2F11/ES/Desarrollo de un parche transdérmico de memantina para el tratamiento de la enfermedad de Alzheimer en fases avanzadas/
Thanks:
The authors wish to thank the "Generalitat Valenciana" (AP-114/09; AP-155/10; AP-175/11) and the "Universidad CEU Cardenal Herrera" for their financial support. The authors also thank Pharsight corp. for the academic license ...[+]
Type: Artículo

This item appears in the following Collection(s)

Show full item record